BPC-157 focuses more directly on repairing damaged tissues
Emerging research continues to show that targeted peptide therapies may support both lifespan and healthspan by working at the cellular level to assist healing and inflammation balance
A new drug application was reportedly submitted in late 2025, putting it closest to potential approval
Many researchers study both in combination because their mechanisms are complementary rather than redundant, which is why Peptides Costa Rica offers a dedicated BPC-157 + TB-500 combination vial.
[DOI] [PubMed] [Google Scholar] 60.Doshi S.N., McDowell I.F., Moat S.J., Payne N., Durrant H.J., Lewis M.J., Goodfellow J
This information is not specific medical advice and does not replace information you receive from your health care provider